TCL1A and acute myeloid leukemia: TCL-1 is expressed in 90% of BPDCN cases and only 17% of c-AML, and it is also seen in a broad variety of B cell lymphoproliferative disorders and some T-cell disorders but is absent in NK cell lineages [19].